Patents by Inventor Susan N. McLaughlin

Susan N. McLaughlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040062754
    Abstract: A method of treating chronic HCV infections is disclosed. The method involves the optional treatment of a patient with interferon alpha and the treatment of a patient's blood with a psoralen compound followed by ultra violet light-activation of the psoralen compound. The blood treated as such is returned to the patient in a process known as extracorporeal photopheresis.
    Type: Application
    Filed: September 19, 2003
    Publication date: April 1, 2004
    Inventors: Christopher B. O'Brien, Susan N. McLaughlin, Bruce C. Stouch
  • Patent number: 5984887
    Abstract: A method of treating infections of mononuclear blood cells, other than retroviral infections, is disclosed. A method of modulating the function of monocytes is also disclosed. The method involves the treatment of a patient's blood with a photoactivatable compound followed by ultra violet light-activation of the photoactivatable compound. The blood treated as such is returned to the patient in a process known as extracorporeal photopheresis. Monocyte function is modulated by this treatment.
    Type: Grant
    Filed: March 26, 1997
    Date of Patent: November 16, 1999
    Assignee: Therakos, Inc.
    Inventors: Susan N. McLaughlin, Bruce C. Stouch, Jerome B. Zeldis